Back to Search Start Over

FORM 8-K: ARVINAS, INC. Files Current Report (May 30, 2024)

Source :
Financial Law Reporter. June 1, 2024
Publication Year :
2024

Abstract

Washington: ARVINAS, INC., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on May 30, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________ [...]

Subjects

Subjects :
United States. Securities and Exchange Commission -- Reports
Novartis Pharma AG -- Reports
Securities law -- Reports
Stock-exchange -- Reports
Pharmaceutical industry -- Reports
News, opinion and commentary
Securities Exchange Act

Details

Language :
English
Database :
Gale General OneFile
Journal :
Financial Law Reporter
Publication Type :
News
Accession number :
edsgcl.797246851

Tools

Authors Abstract Subjects Details